Recent Sentinel Activity

This recent activity feed provides a list of the last 90 days of Sentinel activity across assessments, publications & presentations, projects, events, etc.

RSS Feed

URL	Title	Category	Date	Recent Activity
https://www.sentinelinitiative.org/studies/drugs/provigil-modafinil-and-nuvigil-armodafinil-0	Provigil (Modafinil) and Nuvigil (Armodafinil) & Congenital Cardiac Malformations	Studies	11/17/2020	Provigil (Modafinil) and Nuvigil (Armodafinil) & Congenital Cardiac Malformations Studies 11/17/2020
https://www.sentinelinitiative.org/methods-data-tools/methods/covid-19-pregnancy-study-implementation	COVID-19 Pregnancy Study Implementation	Methods, Data, & Tools	02/24/2021	COVID-19 Pregnancy Study Implementation Methods, Data, & Tools 02/24/2021
https://www.sentinelinitiative.org/studies/drugs/assessing-arias-ability-evaluate-safety-concern/adbry-tralokinumab	Assessment of ARIA Sufficiency: Adbry (tralokinumab)	Sufficiency Assessments	04/08/2021	Assessment of ARIA Sufficiency: Adbry (tralokinumab) Sufficiency Assessments 04/08/2021
https://www.sentinelinitiative.org/studies/drugs/assessing-arias-ability-evaluate-safety-concern/bylvay-odevixibat	Assessment of ARIA Sufficiency: Bylvay (odevixibat)	Sufficiency Assessments	04/08/2021	Assessment of ARIA Sufficiency: Bylvay (odevixibat) Sufficiency Assessments 04/08/2021
https://www.sentinelinitiative.org/studies/drugs/assessing-arias-ability-evaluate-safety-concern/camzyos-mavacamten	Assessment of ARIA Sufficiency: Camzyos (mavacamten)	Sufficiency Assessments	04/08/2021	Assessment of ARIA Sufficiency: Camzyos (mavacamten) Sufficiency Assessments 04/08/2021
https://www.sentinelinitiative.org/studies/drugs/assessing-arias-ability-evaluate-safety-concern/enjaymo-sutimlimab-jome	Assessment of ARIA Sufficiency: Enjaymo (sutimlimab-jome)	Sufficiency Assessments	04/08/2021	Assessment of ARIA Sufficiency: Enjaymo (sutimlimab-jome) Sufficiency Assessments 04/08/2021
https://www.sentinelinitiative.org/studies/drugs/assessing-arias-ability-evaluate-safety-concern/nextstellis-drospirenone-and-estetrol	Assessment of ARIA Sufficiency: Nextstellis (drospirenone and estetrol)	Assessments	04/08/2021	Assessment of ARIA Sufficiency: Nextstellis (drospirenone and estetrol) Assessments 04/08/2021
https://www.sentinelinitiative.org/studies/drugs/assessing-arias-ability-evaluate-safety-concern/quviviq-daridorexant	Assessment of ARIA Sufficiency: Quviviq (daridorexant)	Sufficiency Assessments	04/08/2021	Assessment of ARIA Sufficiency: Quviviq (daridorexant) Sufficiency Assessments 04/08/2021
https://www.sentinelinitiative.org/studies/drugs/assessing-arias-ability-evaluate-safety-concern/reyvow-lasmiditan	Assessment of ARIA Sufficiency: Reyvow (lasmiditan)	Sufficiency Assessments	04/08/2021	Assessment of ARIA Sufficiency: Reyvow (lasmiditan) Sufficiency Assessments 04/08/2021
https://www.sentinelinitiative.org/studies/drugs/assessing-arias-ability-evaluate-safety-concern/voquezna-dual-pak	Assessment of ARIA Sufficiency: Voquezna Dual Pak (vonoprazan/amoxicillin)	Sufficiency Assessments	04/08/2021	Assessment of ARIA Sufficiency: Voquezna Dual Pak (vonoprazan/amoxicillin) Sufficiency Assessments 04/08/2021
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/angioedema-following-sacubitrilvalsartan-use-patients-heart	Angioedema Following Sacubitril/Valsartan Use in Patients with Heart Failure: A Propensity Score Analysis	Modular Programs	04/21/2021	Angioedema Following Sacubitril/Valsartan Use in Patients with Heart Failure: A Propensity Score Analysis Modular Programs 04/21/2021
https://www.sentinelinitiative.org/methods-data-tools/health-outcomes-interest/angioedema-and-serious-angioedema-algorithms-defined	Angioedema and Serious Angioedema Algorithms Defined in "Angioedema following Sacubitril/Valsartan Use in Patients with Heart Failure: A Propensity Score Analysis"	Methods, Data, & Tools	04/21/2021	Angioedema and Serious Angioedema Algorithms Defined in "Angioedema following Sacubitril/Valsartan Use in Patients with Heart Failure: A Propensity Score Analysis" Methods, Data, & Tools 04/21/2021
https://www.sentinelinitiative.org/methods-data-tools/methods/extending-machine-learning-methods-development-sentinel-follow-analyses	Extending Machine Learning Methods Development in Sentinel: Follow-up Analyses for Anaphylaxis Algorithm and Formalization of a General Phenotyping Framework (Phase 3)	Methods, Data, & Tools	05/17/2021	Extending Machine Learning Methods Development in Sentinel: Follow-up Analyses for Anaphylaxis Algorithm and Formalization of a General Phenotyping Framework (Phase 3) Methods, Data, & Tools 05/17/2021
https://www.sentinelinitiative.org/methods-data-tools/methods/longitudinal-trends-incident-and-prevalent-use-long-acting-beta-2	Longitudinal Trends in Incident and Prevalent use of Long-Acting Beta-2 Agonists: An Interrupted Time Series Analysis	Methods, Data, & Tools	08/24/2021	Longitudinal Trends in Incident and Prevalent use of Long-Acting Beta-2 Agonists: An Interrupted Time Series Analysis Methods, Data, & Tools 08/24/2021
https://www.sentinelinitiative.org/news-events/publications-presentations/new-analytic-tool-interrupted-times-series-analysis-assess	A New Analytic Tool for Interrupted Times Series Analysis to Assess the Impact of FDA Regulatory Actions	Publications and Presentations	08/24/2021	A New Analytic Tool for Interrupted Times Series Analysis to Assess the Impact of FDA Regulatory Actions Publications and Presentations 08/24/2021
https://www.sentinelinitiative.org/news-events/publications-presentations/improving-methods-identifying-anaphylaxis-medical-product	Improving Methods of Identifying Anaphylaxis for Medical Product Safety Surveillance Using Natural Language Processing and Machine Learning	Publications and Presentations	08/25/2021	Improving Methods of Identifying Anaphylaxis for Medical Product Safety Surveillance Using Natural Language Processing and Machine Learning Publications and Presentations 08/25/2021
https://www.sentinelinitiative.org/studies/drugs/assessing-arias-ability-evaluate-safety-concern/ubrelvy-ubrogepant	Assessment of ARIA Sufficiency: Ubrelvy (ubrogepant)	Sufficiency Assessments	08/27/2021	Assessment of ARIA Sufficiency: Ubrelvy (ubrogepant) Sufficiency Assessments 08/27/2021
https://www.sentinelinitiative.org/methods-data-tools/methods/making-medicaid-data-more-accessible-through-common-data-models-and-fhir	Making Medicaid Data More Accessible Through Common Data Models and FHIR APIs	Methods, Data, & Tools	09/24/2021	Making Medicaid Data More Accessible Through Common Data Models and FHIR APIs Methods, Data, & Tools 09/24/2021
https://www.sentinelinitiative.org/news-events/publications-presentations/natural-history-coagulopathy-covid-19-0	Natural History of Coagulopathy in COVID-19	Publications and Presentations	10/06/2021	Natural History of Coagulopathy in COVID-19 Publications and Presentations 10/06/2021
https://www.sentinelinitiative.org/news-events/meetings-workshops-trainings/2022-sentinel-community-building-and-outreach-center	2022 Sentinel Community Building and Outreach Center Webinar Series	Sentinel Initiative Events	11/23/2021	2022 Sentinel Community Building and Outreach Center Webinar Series Sentinel Initiative Events 11/23/2021
https://www.sentinelinitiative.org/news-events/meetings-workshops-trainings/2022-sentinel-innovation-and-methods-seminar-series	2022 Sentinel Innovation and Methods Seminar Series	Sentinel Initiative Events	01/01/2022	2022 Sentinel Innovation and Methods Seminar Series Sentinel Initiative Events 01/01/2022
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/mometasone-furoate-sinus-implant-use-patients-nasal-polyps	Mometasone Furoate Sinus Implant Use in Patients with Nasal Polyps: A Descriptive Analysis	Analyses	03/03/2022	Mometasone Furoate Sinus Implant Use in Patients with Nasal Polyps: A Descriptive Analysis Analyses 03/03/2022
https://www.sentinelinitiative.org/engage-sentinel/quarterly-newsletter	Quarterly Newsletter	Spotlight	03/24/2022	Quarterly Newsletter Spotlight 03/24/2022
https://www.sentinelinitiative.org/methods-data-tools/methods/approaches-handling-partially-observed-confounder-data-electronic-health	Approaches to Handling Partially Observed Confounder Data From Electronic Health Records (EHR) In Non-randomized Studies of Medication Outcomes	Methods, Data, & Tools	06/01/2022	Approaches to Handling Partially Observed Confounder Data From Electronic Health Records (EHR) In Non-randomized Studies of Medication Outcomes Methods, Data, & Tools 06/01/2022
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/utilization-sodium-glucose-co-transporter-2-sglt-2-inhibitor	Utilization of Sodium Glucose Co-Transporter-2 (SGLT-2) Inhibitor Drugs: A Descriptive Analysis	Analyses	07/11/2022	Utilization of Sodium Glucose Co-Transporter-2 (SGLT-2) Inhibitor Drugs: A Descriptive Analysis Analyses 07/11/2022
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/utilization-obesity-drugs-descriptive-analysis	Utilization of Obesity Drugs: A Descriptive Analysis	Analyses	08/05/2022	Utilization of Obesity Drugs: A Descriptive Analysis Analyses 08/05/2022
https://www.sentinelinitiative.org/news-events/publications-presentations/association-covid-19-vs-influenza-risk-arterial-and-venous	Association of COVID-19 vs Influenza with Risk of Arterial and Venous Thrombotic Events Among Hospitalized Patients	Publications and Presentations	08/16/2022	Association of COVID-19 vs Influenza with Risk of Arterial and Venous Thrombotic Events Among Hospitalized Patients Publications and Presentations 08/16/2022
https://www.sentinelinitiative.org/news-events/publications-presentations/impact-nitrosamine-contamination-recalls-angiotensin	Impact of Nitrosamine Contamination Recalls on Angiotensin-Receptor-Blocker (ARB) Utilization in the U.S., U.K., Canada, and Denmark	Publications and Presentations	08/26/2022	Impact of Nitrosamine Contamination Recalls on Angiotensin-Receptor-Blocker (ARB) Utilization in the U.S., U.K., Canada, and Denmark Publications and Presentations 08/26/2022
https://www.sentinelinitiative.org/news-events/publications-presentations/racial-differences-us-covid-19-positivity-hospitalization	Racial Differences in U.S. COVID-19 Positivity, Hospitalization, and Mortality	Spotlight	08/28/2022	Racial Differences in U.S. COVID-19 Positivity, Hospitalization, and Mortality Spotlight 08/28/2022
https://www.sentinelinitiative.org/methods-data-tools/sentinel-national-resource/patient-characteristics-pain-treatment-patterns-and	Patient Characteristics, Pain Treatment Patterns, and Incidence of Total Joint Replacement in a US Population With Osteoarthritis		09/23/2022	Patient Characteristics, Pain Treatment Patterns, and Incidence of Total Joint Replacement in a US Population With Osteoarthritis 09/23/2022
https://www.sentinelinitiative.org/news-events/publications-presentations/association-covid-19-vs-influenza-risk-arterial-and-venous-0	Association of COVID-19 vs Influenza with Risk of Arterial and Venous Thrombotic Events Among Hospitalized Patients	Publications and Presentations	10/20/2022	Association of COVID-19 vs Influenza with Risk of Arterial and Venous Thrombotic Events Among Hospitalized Patients Publications and Presentations 10/20/2022
https://www.sentinelinitiative.org/news-events/publications-presentations/spironolactone-utilization-among-patients-reduced-and	Spironolactone Utilization among Patients with Reduced and Preserved Ejection Fraction Heart Failure	Publications and Presentations	10/20/2022	Spironolactone Utilization among Patients with Reduced and Preserved Ejection Fraction Heart Failure Publications and Presentations 10/20/2022
https://www.sentinelinitiative.org/methods-data-tools/methods/onboarding-commercial-electronic-health-record-ehr-data-partners	Onboarding of Commercial Electronic Health Record (EHR) Data Partners	Methods, Data, & Tools	11/01/2022	Onboarding of Commercial Electronic Health Record (EHR) Data Partners Methods, Data, & Tools 11/01/2022
https://www.sentinelinitiative.org/methods-data-tools/software-packages-toolkits/centers-medicare-and-medicaid-services-cms-medicaid	The Centers for Medicare and Medicaid Services (CMS): Medicaid and Children’s Health Insurance Program (CHIP) Claims in Sentinel Common Data Model (SCDM) Format	Methods, Data, & Tools	11/01/2022	The Centers for Medicare and Medicaid Services (CMS): Medicaid and Children’s Health Insurance Program (CHIP) Claims in Sentinel Common Data Model (SCDM) Format Methods, Data, & Tools 11/01/2022
https://www.sentinelinitiative.org/news-events/publications-presentations/new-analytic-tool-assessing-impact-us-food-and-drug	A New Analytic Tool for Assessing the Impact of the US Food and Drug Administration Regulatory Actions	Publications and Presentations	11/04/2022	A New Analytic Tool for Assessing the Impact of the US Food and Drug Administration Regulatory Actions Publications and Presentations 11/04/2022
https://www.sentinelinitiative.org/news-events/publications-presentations/improving-methods-identifying-anaphylaxis-medical-product-0	Improving Methods of Identifying Anaphylaxis for Medical Product Safety Surveillance Using Natural Language Processing and Machine Learning	Publications and Presentations	11/04/2022	Improving Methods of Identifying Anaphylaxis for Medical Product Safety Surveillance Using Natural Language Processing and Machine Learning Publications and Presentations 11/04/2022
https://www.sentinelinitiative.org/news-events/publications-presentations/data-driven-automated-classification-algorithms-acute-health	Data-Driven Automated Classification Algorithms for Acute Health Conditions: Applying PheNorm to COVID 19 Disease	Publications and Presentations	11/07/2022	Data-Driven Automated Classification Algorithms for Acute Health Conditions: Applying PheNorm to COVID 19 Disease Publications and Presentations 11/07/2022
https://www.sentinelinitiative.org/news-events/publications-presentations/assessing-medical-product-safety-during-pregnancy-using	Assessing Medical Product Safety During Pregnancy using Parameterizable Tools in the Sentinel Distributed Database	Publications and Presentations	11/09/2022	Assessing Medical Product Safety During Pregnancy using Parameterizable Tools in the Sentinel Distributed Database Publications and Presentations 11/09/2022
https://www.sentinelinitiative.org/studies/drugs/ozempic-semaglutide	Ozempic (Semaglutide) & Signal Identification	Studies	11/10/2022	Ozempic (Semaglutide) & Signal Identification Studies 11/10/2022
https://www.sentinelinitiative.org/studies/drugs/zarxio-filgrastim-sndz	Zarxio (Filgrastim-sndz) & Signal Identification	Studies	11/10/2022	Zarxio (Filgrastim-sndz) & Signal Identification Studies 11/10/2022